EGFR c.2117T>C ;(p.I706T)

Variant ID: 7-55241669-T-C

NM_005228.3(EGFR):c.2117T>C;(p.I706T)

This variant was identified in 23 publications

View GRCh38 version.




Publications:


Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need.

International Journal Of Molecular Sciences
Pretelli, Giulia G; Spagnolo, Calogera Claudia CC; Ciappina, Giuliana G; Santarpia, Mariacarmela M; Pasello, Giulia G
Publication Date: 2023-05-17

Variant appearance in text: EGFR: I706T
PubMed Link: 37240224
Variant Present in the following documents:
  • Main text
  • ijms-24-08878.pdf
View BVdb publication page



Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer.

Frontiers In Genetics
G, Vigneshwaran V; Hasan, Qurratulain Annie QA; Kumar, Rahul R; Eranki, Avinash A
Publication Date: 2022

Variant appearance in text: rs397517084
PubMed Link: 36561320
Variant Present in the following documents:
  • Table2.xlsx, sheet 4
View BVdb publication page



Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Frontiers In Oncology
Dong, Wei W; Wang, Congjie C; Wang, Chunsheng C; Zhao, Kewei K; Ma, Zhao Z; Hu, Shanliang S
Publication Date: 2022

Variant appearance in text: EGFR: I706T
PubMed Link: 36425553
Variant Present in the following documents:
  • DataSheet_1.pdf
View BVdb publication page



Development and Validation of a Concise Prediction Scoring System for Asian Lung Cancer Patients with EGFR Mutation Before Treatment.

Technology In Cancer Research & Treatment
An, Wenting W; Fan, Wei W; Zhong, Feiyang F; Wang, Binchen B; Wang, Shan S; Gan, Tian T; Tian, Sufang S; Liao, Meiyan M
Publication Date: 2022

Variant appearance in text: EGFR: I706T
PubMed Link: 35234540
Variant Present in the following documents:
  • Main text
  • 10.1177_15330338221078732.pdf
View BVdb publication page



Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC.

Jto Clinical And Research Reports
Hondelink, Liesbeth M LM; Jebbink, Merel M; von der Thüsen, Jan H JH; Cohen, Danielle D; Dubbink, Hendrikus J HJ; Paats, Marthe S MS; Dingemans, Anne-Marie C AC; de Langen, Adrianus J AJ; Boelens, Mirjam C MC; Smit, Egbert F EF; Postmus, Pieter E PE; van Wezel, Tom T; Monkhorst, Kim K
Publication Date: 2021-12

Variant appearance in text: EGFR: I706T
PubMed Link: 34849493
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.

Jto Clinical And Research Reports
Enrico, Diego D; Lacroix, Ludovic L; Chen, Jeanne J; Rouleau, Etienne E; Scoazec, Jean-Yves JY; Loriot, Yohann Y; Tselikas, Lambros L; Jovelet, Cécile C; Planchard, David D; Gazzah, Anas A; Mezquita, Laura L; Ngo-Camus, Maud M; Michiels, Stefan S; Massard, Christophe C; Recondo, Gonzalo G; Facchinetti, Francesco F; Remon, Jordi J; Soria, Jean-Charles JC; André, Fabrice F; Vassal, Gilles G; Friboulet, Luc L; Besse, Benjamin B
Publication Date: 2020-06

Variant appearance in text: EGFR: I706T
PubMed Link: 34589930
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutation Spectrum of EGFR From 21,324 Chinese Patients With Non-Small Cell Lung Cancer (NSCLC) Successfully Tested by Multiple Methods in a CAP-Accredited Laboratory.

Pathology Oncology Research : Por
Mao, Linlin L; Zhao, Weiwei W; Li, Xiaoxia X; Zhang, Shangfei S; Zhou, Changhong C; Zhou, Danyan D; Ou, Xiaohua X; Xu, Yanyan Y; Tang, Yuanxiao Y; Ou, Xiaoyong X; Hu, Changming C; Ding, Xiangdong X; Luo, Pifu P; Yu, Shihui S
Publication Date: 2021

Variant appearance in text: EGFR: I706T
PubMed Link: 34257561
Variant Present in the following documents:
  • Main text
  • pore-27-602726.pdf
View BVdb publication page



Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice.

Journal Of Thoracic Disease
González de Aledo-Castillo, José Manuel JM; Arcocha, Ainara A; Victoria, Iván I; Martinez-Puchol, Ana Isabel AI; Sánchez, Cristina C; Jares, Pedro P; Rodríguez, Gabriel Felipe GF; Viñolas, Núria N; Reyes, Roxana R; Reguart, Noemí N; Puig-Butillé, Joan Antón JA
Publication Date: 2021-03

Variant appearance in text: EGFR: Ile706Thr
PubMed Link: 33841957
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.

Thoracic Cancer
Nam, Yunha Y; Kim, Ho Cheol HC; Kim, Young-Chul YC; Jang, Seung Hun SH; Lee, Kye Young KY; Lee, Shin Yup SY; Lee, Sang Hoon SH; Lee, Sung Yong SY; Yoon, Seong Hoon SH; Ryu, Jeong-Seon JS; Jang, Tae Won TW; Chang, Yoon Soo YS; Kim, Seung Joon SJ; Park, Chan Kwon CK; Lee, Jeong Eun JE; Jung, Chi Young CY; Choi, Chang-Min CM
Publication Date: 2021-03

Variant appearance in text: EGFR: I706T
PubMed Link: 33529490
Variant Present in the following documents:
  • Main text
  • TCA-12-890.pdf
View BVdb publication page



Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario.

International Journal Of Molecular Sciences
Russo, Alessandro A; Franchina, Tindara T; Ricciardi, Giuseppina G; Battaglia, Alessandra A; Picciotto, Maria M; Adamo, Vincenzo V
Publication Date: 2019-03-21

Variant appearance in text: EGFR: I706T
PubMed Link: 30901844
Variant Present in the following documents:
  • Main text
  • ijms-20-01431.pdf
View BVdb publication page



Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.

Cancers
Tsai, Ming-Ju MJ; Hung, Jen-Yu JY; Lee, Mei-Hsuan MH; Kuo, Chia-Yu CY; Tsai, Yu-Chen YC; Tsai, Ying-Ming YM; Liu, Ta-Chih TC; Yang, Chih-Jen CJ; Huang, Ming-Shyan MS; Chong, Inn-Wen IW
Publication Date: 2018-11-13

Variant appearance in text: EGFR: I706T
PubMed Link: 30428509
Variant Present in the following documents:
  • Main text
  • cancers-10-00434.pdf
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: EGFR: I706T
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 2
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



Clinical mutational profiling of 1006 lung cancers by next generation sequencing.

Oncotarget
Illei, Peter B PB; Belchis, Deborah D; Tseng, Li-Hui LH; Nguyen, Doreen D; De Marchi, Federico F; Haley, Lisa L; Riel, Stacy S; Beierl, Katie K; Zheng, Gang G; Brahmer, Julie R JR; Askin, Frederic B FB; Gocke, Christopher D CD; Eshleman, James R JR; Forde, Patrick M PM; Lin, Ming-Tseh MT
Publication Date: 2017-11-14

Variant appearance in text: EGFR: I706T
PubMed Link: 29228562
Variant Present in the following documents:
  • oncotarget-08-96684.pdf
View BVdb publication page



Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors.

Erj Open Research
Wu, Shang-Gin SG; Chang, Yih-Leong YL; Yu, Chong-Jen CJ; Yang, Pan-Chyr PC; Shih, Jin-Yuan JY
Publication Date: 2017-07

Variant appearance in text: EGFR: I706T
PubMed Link: 28717642
Variant Present in the following documents:
  • Main text
  • 00092-2016.pdf
View BVdb publication page



Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer.

Chinese Medical Journal
Ye, Qing Q; Qi, Fan F; Bian, Li L; Zhang, Shao-Hua SH; Wang, Tao T; Jiang, Ze-Fei ZF
Publication Date: 2017-03-05

Variant appearance in text: EGFR: I706T
PubMed Link: 28229982
Variant Present in the following documents:
  • CMJ-130-522.pdf
View BVdb publication page



Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy.

Cancer Science
Kobayashi, Yoshihisa Y; Mitsudomi, Tetsuya T
Publication Date: 2016-09

Variant appearance in text: EGFR: I706T
PubMed Link: 27323238
Variant Present in the following documents:
  • Main text
  • CAS-107-1179.pdf
View BVdb publication page



Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma.

Cancer Biology & Therapy
Kim, Eun Young EY; Cho, Eun Na EN; Park, Heae Surng HS; Hong, Ji Young JY; Lim, Seri S; Youn, Jong Pil JP; Hwang, Seung Yong SY; Chang, Yoon Soo YS
Publication Date: 2016

Variant appearance in text: EGFR: I706T
PubMed Link: 26785607
Variant Present in the following documents:
  • Main text
  • kcbt-17-03-1139235.pdf
View BVdb publication page



Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.

Oncotarget
Pécuchet, Nicolas N; Laurent-Puig, Pierre P; Mansuet-Lupo, Audrey A; Legras, Antoine A; Alifano, Marco M; Pallier, Karine K; Didelot, Audrey A; Gibault, Laure L; Danel, Claire C; Just, Pierre-Alexandre PA; Riquet, Marc M; Le Pimpec-Barthes, Françoise F; Damotte, Diane D; Fabre, Elisabeth E; Blons, Hélène H
Publication Date: 2017-04-04

Variant appearance in text: EGFR: I706T
PubMed Link: 26625312
Variant Present in the following documents:
  • oncotarget-08-23831-s002.xls, sheet 1
View BVdb publication page



EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis.

Scientific Reports
Cheng, Chao C; Wang, Rui R; Li, Yuan Y; Pan, Yunjian Y; Zhang, Yang Y; Li, Hang H; Zheng, Difan D; Zheng, Shanbo S; Shen, Xuxia X; Sun, Yihua Y; Chen, Haiquan H
Publication Date: 2015-09-10

Variant appearance in text: EGFR: I706T
PubMed Link: 26354324
Variant Present in the following documents:
  • Main text
View BVdb publication page



Elderly former smoker with HRAS mutant non-small-cell lung cancer.

Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer
Cathcart-Rake, Elizabeth E; Corless, Christopher C; Sauer, David D; Lopez-Chavez, Ariel A
Publication Date: 2014-10

Variant appearance in text: EGFR: I706T
PubMed Link: 25521407
Variant Present in the following documents:
  • jto-9-e075.pdf
View BVdb publication page



Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.

Plos One
Tseng, Jeng-Sen JS; Wang, Chih-Liang CL; Huang, Ming-Shyan MS; Chen, Chung-Yu CY; Chang, Cheng-Yu CY; Yang, Tsung-Ying TY; Tsai, Chi-Ren CR; Chen, Kun-Chieh KC; Hsu, Kuo-Hsuan KH; Tsai, Meen-Hsin MH; Yu, Sung-Liang SL; Su, Kang-Yi KY; Wu, Chih-Wei CW; Yang, Cheng-Ta CT; Chen, Yuh-Min YM; Chang, Gee-Chen GC
Publication Date: 2014

Variant appearance in text: EGFR: I706T
PubMed Link: 25215536
Variant Present in the following documents:
  • Main text
  • pone.0107160.pdf
View BVdb publication page



Co-conserved features associated with cis regulation of ErbB tyrosine kinases.

Plos One
Mirza, Amar A; Mustafa, Morad M; Talevich, Eric E; Kannan, Natarajan N
Publication Date: 2010-12-13

Variant appearance in text: EGFR: I706T
PubMed Link: 21179209
Variant Present in the following documents:
  • Main text
  • pone.0014310.pdf
View BVdb publication page